November 22, 2023 — Siemens Healthineers has announced the U.S. Food and Drug Administration (FDA) clearance of the ...
PET Imaging
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.
November 21, 2023 — Heuron, a medical AI (artificial intelligence) imaging software solution company, under the ...
November 21, 2023 — GE HealthCare has received U.S. FDA 510(k) Clearance for the new version of Digital Expert Access ...
Digital technology is opening remarkable opportunities for clinical positron emission tomography (PET) about which ...
November 8, 2023 — In a small study, researchers at the National Institutes of Health have found that positron emission ...
November 6, 2023 — Meilleur Technologies, Inc. announced a research collaboration agreement with the National Institute ...
October 26, 2023 — A more refined approach to the precise removal of brain tumors is on the horizon. The long ...
Precision can have an enormous impact on patients. From diagnosis to patient monitoring (see “How Digital PET/CT Can ...
October 24, 2023 — The Centers for Medicare and Medicaid Services (CMS) recently released its final National Coverage ...
October 20, 2023 — Meilleur Technologies, Inc. announced a research collaboration agreement with the Alzheimer’s Disease ...
October 18, 2023 — The Centers for Medicare and Medicaid Services (CMS) announced it will no longer require coverage ...
PET is getting ready to venture outside oncology, cardiology and mainstream neurology. High on the list of new clinical ...
October 11, 2023 — GE HealthCare today announced an exclusive global licensing agreement with SOFIE Biosciences (SOFIE) ...
October 11, 2023 — A new imaging agent, 68Ga-ABY-025, can predict early metabolic response to human epidermal growth ...
October 5, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...
Analog is approximate. Digital is specific. Therein lies the fundamental difference between digital PET and its analog ...
September 28, 2023 — RefleXion Medical, a therapeutic oncology company, announced the company will showcase the ...
Since the advent of the magnetic resonance imaging (MRI) exam on human patients in the late 1970s, this innovation ...
September 21, 2023 — Scientists in Moscow have successfully engineered a prototype detector for X-ray and PET/CT ...
September 8, 2023 — Positron Corporation, a leading molecular imaging medical device company, is pleased to announce ...
September 7, 2023 — The groundbreaking AURA 10 specimen imager by Belgian MedTech pioneer XEOS has been cleared by the ...
According to a new report from Transparency Market Research (TMR), PET radiotracers are expected to rise at a CAGR of 8 ...
August 15, 2023 — In elderly patients with suspected prostate cancer, PSMA PET/CT can diagnose advanced disease and aid ...
The healthcare industry faces many different types of obstacles in today’s challenging marketplace. Staff shortages ...